Stocks extended their "Santa Claus" rally to a sixth day, with
the Dow Jones Industrial Average climbing to a fresh record
Wednesday in a shortened session ahead of the Christmas holiday
while late selling pulled the S&P 500 off its earlier record.
Gains today were supported by more signs of a strengthening labor
market, with first-time applications for unemployment insurance
falling to 280,000 last week, down 9,000 claims from the prior
week's revised level.
Most industry sectors in the S&P 500 posted moderate gains,
although shares of health care companies recorded outsized advances
after lagging the broader markets earlier this week. Energy and
mining stocks fell as crude oil took another spill and gold traded
lower through most of the day. But utility stocks notched big
advances with falling energy prices expected to boost industry
earnings in the future.
Crude oil for February delivery was down $1.36 to $55.78 per
barrel in afternoon trade while January natural gas was off 14
cents at $3.03 per 1 million BTU. February gold was ahead 50 cents
at $1,174 per ounce as the U.S. dollar backed away from its recent
Here's where the U.S. markets stood at the end-of-day:
Dow Jones Industrial Average up 6.04 (+0.03%) to 18,030.21
S&P 500 down 0.29 (-0.01%) to 2,081.88
Nasdaq Composite Index up 8.05 (+0.17%) to 4,773.47
Hang Seng Index up 0.07%
Shanghai China Composite Index down 1.98%
FTSE 100 Index up 0.18%
(+) ANFI, raises FY15 guidance; forecasting 25% growth in
revenue and adjusted EBITDA over year-ago levels. Company
previously expected 20% rise for adjusted EBITDA this year. Street
is expecting FY15 revenue to grow 25.8% over prior year.
(+) ADMS, U.S. regulators approve new drug application for its
Namzaric medication to treat Alzheimer's-type dementia. The company
is expecting a 2015 commercial launch by Activis (
) for the combination of complementary drugs that are often
(+) ACHN, (+10.0%) Piper Jaffray today reiterates Overweight
rating and $22.50 price target, with analyst Edward Tenthoff
writing recent price weakness has created a buying opportunity for
(-) CUBA, Company president Thomas Herzfeld discloses sale of
200,000 shares in Dec. 22 regulatory filing, pocketing $2.46
million after selling 100,000 shares at $11.51 apiece and another
100,000 shares at $13.08 each.
(-) CAMP, Sees fiscal Q4 revenue in a range of $66 million to
$70 million, lagging the Capital IQ consensus by at least $1.2
million. Weak outlook for current quarter upstages Q3 adjusted
earnings beating estimates by $0.02 per share.
(-) EXXI, Shares held by short-seller rise nearly 1% over prior
reporting period to 18.19 mln shares on Nov. 28, now representing
19.9% of the stock's float, which are the shares not held by
insiders and are widely available for trading.